200 related articles for article (PubMed ID: 23761098)
1. Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity.
Stojan G; Fang H; Magder L; Petri M
Lupus; 2013 Jul; 22(8):827-34. PubMed ID: 23761098
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual.
Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
J Rheumatol; 2005 Nov; 32(11):2150-5. PubMed ID: 16265693
[TBL] [Abstract][Full Text] [Related]
3. Seasonal variation in the activity of systemic lupus erythematosus.
Duarte-García A; Fang H; To CH; Magder LS; Petri M
J Rheumatol; 2012 Jul; 39(7):1392-8. PubMed ID: 22660806
[TBL] [Abstract][Full Text] [Related]
4. Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus.
Mertz P; Piga M; Chessa E; Amoura Z; Voll RE; Schwarting A; Maurier F; Blaison G; Bonnotte B; Poindron V; Fiehn C; Lorenz HM; Korganow AS; Sibilia J; Martin T; Arnaud L
RMD Open; 2022 Sep; 8(2):. PubMed ID: 36123013
[TBL] [Abstract][Full Text] [Related]
5. The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.
Ribi C; Trendelenburg M; Gayet-Ageron A; Cohen C; Dayer E; Eisenberger U; Hauser T; Hunziker T; Leimgruber A; Lindner G; Koenig K; Otto P; Spertini F; Stoll T; Von Kempis J; Chizzolini C;
Swiss Med Wkly; 2014; 144():w13990. PubMed ID: 25115978
[TBL] [Abstract][Full Text] [Related]
6. A pilot study to determine the optimal timing of the Physician Global Assessment (PGA) in patients with systemic lupus erythematosus.
Aranow C
Immunol Res; 2015 Dec; 63(1-3):167-9. PubMed ID: 26514813
[TBL] [Abstract][Full Text] [Related]
7. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
Ho A; Barr SG; Magder LS; Petri M
Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
[TBL] [Abstract][Full Text] [Related]
8. Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients.
FitzGerald JD; Grossman JM
Lupus; 1999; 8(8):638-44. PubMed ID: 10568901
[TBL] [Abstract][Full Text] [Related]
9. Does erythrocyte sedimentation rate reflect and discriminate flare from infection in systemic lupus erythematosus? Correlation with clinical and laboratory parameters of disease activity.
Schäfer VS; Weiß K; Krause A; Schmidt WA
Clin Rheumatol; 2018 Jul; 37(7):1835-1844. PubMed ID: 29656375
[TBL] [Abstract][Full Text] [Related]
10. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M
Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587
[TBL] [Abstract][Full Text] [Related]
11. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.
Ho A; Magder LS; Barr SG; Petri M
Arthritis Rheum; 2001 Oct; 44(10):2342-9. PubMed ID: 11665975
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.
Kao AH; Navratil JS; Ruffing MJ; Liu CC; Hawkins D; McKinnon KM; Danchenko N; Ahearn JM; Manzi S
Arthritis Rheum; 2010 Mar; 62(3):837-44. PubMed ID: 20187154
[TBL] [Abstract][Full Text] [Related]
13. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
[TBL] [Abstract][Full Text] [Related]
14. Addition of constitutional symptoms to the SLEDAI-2K improves overall disease activity assessment: A pilot study.
Anderson EW; Sansone M; Shah B; Kline M; Franchin G; Aranow C; Mackay M
Lupus; 2024 Jul; 33(8):840-850. PubMed ID: 38664230
[TBL] [Abstract][Full Text] [Related]
15. Small changes in outpatients lupus activity are better detected by clinical instruments than by laboratory tests.
Fortin PR; Abrahamowicz M; Danoff D
J Rheumatol; 1995 Nov; 22(11):2078-83. PubMed ID: 8596148
[TBL] [Abstract][Full Text] [Related]
16. The contribution of resting heart rate and routine blood tests to the clinical assessment of disease activity in systemic lupus erythematosus.
Guzmán J; Cardiel MH; Arce-Salinas A; Alarcón-Segovia D
J Rheumatol; 1994 Oct; 21(10):1845-8. PubMed ID: 7837148
[TBL] [Abstract][Full Text] [Related]
17. Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio.
Cipriano E; Ceccarelli F; Massaro L; Spinelli FR; Alessandri C; Perricone C; Valesini G; Conti F
Reumatismo; 2015 Sep; 67(2):62-7. PubMed ID: 26492964
[TBL] [Abstract][Full Text] [Related]
18. Impact of disease activity on health-related quality of life in systemic lupus erythematosus - a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
Chaigne B; Chizzolini C; Perneger T; Trendelenburg M; Huynh-Do U; Dayer E; Stoll T; von Kempis J; Ribi C;
BMC Immunol; 2017 Mar; 18(1):17. PubMed ID: 28351341
[TBL] [Abstract][Full Text] [Related]
19. Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic.
Nasiri S; Karimifar M; Bonakdar ZS; Salesi M
Rheumatol Int; 2010 Nov; 30(12):1605-9. PubMed ID: 19809816
[TBL] [Abstract][Full Text] [Related]
20. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.
Niederkorn A; Frühauf J; Schwantzer G; Wutte N; Painsi C; Werner S; Stradner M; Berghold A; Hermann J; Aberer E
Arch Dermatol Res; 2018 Aug; 310(6):485-493. PubMed ID: 29728857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
